Skip to content
Try Mental Wellness – Lifestyle
Author:
TELA Bio, Inc.
TELA Bio to Announce Third Quarter 2026 Financial Results
October 27, 2026
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement
October 5, 2026
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
August 31, 2026
TELA Bio Reports Second Quarter 2026 Financial Results
August 10, 2026
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 5, 2026
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
August 4, 2026
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
July 29, 2026
TELA Bio to Announce Second Quarter 2026 Financial Results
July 20, 2026
TELA Bio Reports First Quarter 2026 Financial Results
May 12, 2026
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 7, 2026